Latest Earnings Results: Q2 '26
Estimated EPS
$0.44
Reported EPS
$0.46
Surprise
+4.55%
Estimated Rev
$20.35M
Reported Rev
$20.47M
Surprise
+0.57%
• Reported GAAP EPS of $0.41 down -8.89% YoY • Reported revenue of $20.47M up 0.28% YoY • For the third quarter of 2026, Iradimed expects revenue of $23.0 million to $24.5 million, GAAP diluted earnings per share of $0.49 to $0.54, and non-GAAP diluted earnings per share of $0.54 to $0.59.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.55 | -- | -- | N/A |
Q2 '26 | $0.44 | $0.46 | 4.55% | BEAT |
Q1 '26 | $0.44 | $0.49 | 10.11% | BEAT |
Q4 '25 | $0.48 | $0.54 | 12.50% | BEAT |
Q3 '25 | $0.46 | $0.47 | 3.30% | BEAT |